Multi-pathway control of the proliferation versus meiotic development decision in the Caenorhabditis elegans germline.
An important event in the development of the germline is the initiation of meiotic development. In Caenorhabditis elegans, the conserved GLP-1/Notch signaling pathway regulates the proliferative versus meiotic entry decision, at least in part, by spatially inhibiting genes in the gld-1 and gld-2 parallel pathways, which are proposed to either inhibit proliferation and/or promote meiotic development. Mutations that cause constitutive activation of the GLP-1 pathway, or inactivation of both the gld-1 and gld-2 parallel pathways, result in a tumorous germline in which all cells are thought to be proliferative. Here, to analyze proliferation and meiotic entry in wild-type and mutant tumorous germlines, we use anti-REC-8 and anti-HIM-3 specific antibodies as markers, which under our fixation conditions, stain proliferative and meiotic cells, respectively. Using these makers in wild-type animals, we find that the border of the switch from proliferation to meiotic entry is staggered in late-larval and adult germlines. In wild-type adults, the switch occurs between 19 and 26 cell diameters from the distal end, on average. Our analysis of mutants reveals that tumorous germlines that form when GLP-1 is constitutively active are completely proliferative, while tumors due to inactivation of the gld-1 and gld-2 pathways show evidence of meiotic entry. Genetic and time course studies suggest that a third pathway may exist, parallel to the GLD-1 and GLD-2 pathways, that promotes meiotic development.
Hansen
Dave
D
Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Hubbard
E Jane Albert
EJ
Schedl
Tim
T
D000818:Animals; D015415:Biomarkers; D017173:Caenorhabditis elegans / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D029742:Caenorhabditis elegans Proteins / Q000276:immunology; D002455:Cell Division / Q000502:physiology; D005854:Germ Cells / Q000276:immunology / Q000502:physiology*; D005934:Glucagon / Q000378:metabolism; D052216:Glucagon-Like Peptide 1; D008540:Meiosis / Q000502:physiology*; D008938:Mitosis / Q000502:physiology*; D009369:Neoplasms / Q000378:metabolism; D010446:Peptide Fragments / Q000378:metabolism; D010750:Phosphoproteins / Q000276:immunology; D011498:Protein Precursors / Q000378:metabolism; D029702:Schizosaccharomyces pombe Proteins / Q000276:immunology; D015398:Signal Transduction / Q000502:physiology; D000097722:Cohesins
D015415:Biomarkers; D029742:Caenorhabditis elegans Proteins; D005934:Glucagon; D052216:Glucagon-Like Peptide 1; D010446:Peptide Fragments; D010750:Phosphoproteins; D011498:Protein Precursors; D029702:Schizosaccharomyces pombe Proteins; C121599:HIM-3 protein, C elegans; C077081:REC8 protein, S pombe; D000097722:Cohesins